ARCHIVES

Biotech Organization Endorses Measures On Orphan Drug Act

This article is from The Cancer Letter archive.

Vol. 20 No. 13 | April 1, 1994

Download PDF Visit The Full Archive

Related Articles

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

April issue of Business & Regulatory Report included (8 additional pages).

April 30, 2004

In Brief: Reorganization Package Wending Its Way Through The Bureaucracy; FDA Seeks Names for Committee

November 30, 1979

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

Gulf Health Study Begun With $10 Million Each from NIH, BP

September 24, 2010